Professor & patients' paper on the solvable biological challenge of ME/CFS: reader-friendly version
Simon McGrath provides a patient-friendly version of a peer-reviewed paper which highlights some of the most promising biomedical research on ME/CFS ...
Discuss the article on the Forums.

Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases

Discussion in 'Other Health News and Research' started by Bob, Jul 16, 2015.

  1. Bob

    Bob

    Messages:
    9,844
    Likes:
    33,946
    England (south coast)
    This review may be of interest to people with IBS, or various gut issues, or who suspect leaky gut, etc.

    It came to my attention via Erica Verrillo on Twitter, who said:
    "Interesting review showing anti-inflammatory benefits of rifaximin for IBS, Crohn's, liver cirrhosis & more."



    Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases.
    DuPont HL.
    2015 Jul 7.
    Mayo Clin Proc. [Epub ahead of print]
    doi: 10.1016/j.mayocp.2015.04.016.
    http://www.ncbi.nlm.nih.gov/pubmed/26162610
     
    Crux, nandixon and aimossy like this.

See more popular forum discussions.

Share This Page